Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideCMECME Group
FinDog View：Bullish
MSMorgan Stanley
FinDog View：Bullish
| Metric | CME | MS |
|---|
| Close | 303.14 | 184.30 |
| Market Cap | $109B | $288B |
| 1M | +15.71% | −2.01% |
| P/E (TTM) | 24.8 | 14.2 |
| Forward P/E | 21.0 | 14.9 |
| P/E 5-Yr Percentile | 43 | 7 |
| P/S | 8.6 | 2.2 |
| P/B | 4.1 | 2.5 |
| Dividend Yield | 2.03% | 4.32% |
| Latest Quarter Revenue | $1.7B | $21.3B |
| Revenue YoY | +13.0% | +27.1% |
| Gross Margin | — | — |
| Latest Quarter EPS | 2.89 | 3.46 |
| Avg Post-Earnings Move | ±0.7% | ±2.4% |
| EPS Beat Rate | — | 1 / 1 |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 3.74% | 2.35% |
| 90-Day Net Insider Buying | −$5.8M | — |
CME · Revenue, Last 8 Quarters ($B)
MS · Revenue, Last 8 Quarters ($B)
